KRT19 and thyroid gland papillary carcinoma: In the end, we may make few conclusions: CK19 can help in diagnosis of papillary thyroid carcinoma, but one must take into account the intensity and distribution of marker within the tumour; CK19 intensive immunoreactivity, plus missing criteria for PTC, should alert on possibility of malignancy; due to its relatively low specificity, we recommend the use of marker in combination with others.